Alzheimer’s Disease… micronutrients for the ageing brain

In our aging society, Alzheimer’s type dementia is a major concern. The disease can have a devastating impact on quality of life, with patients relying on caregivers for standard daily living activities and there is often a sense of anxiousness and loss for the families involved. Whether it is memory impairment, deterioration, confusion or anger suffered by patients, this highly disruptive neurological disease demands attention. To date, no pharmacological interventions have changed the progression of Alzheimer’s disease. DSM has recently published a new paper which argues that, to delay the onset of Alzheimer’s, neuronal health must be maintained for as long as possible. Here, Professor Manfred Eggersdorfer, Professor of Healthy Ageing at the University of Groningen and Senior Vice-President, Nutrition Science & Advocacy at DSM and Dr. M. Hasan Mohajeri, R&D Human Nutrition and Health at DSM explain why the optimal supply of micronutrients plays a vital metabolic role in supporting the normal functioning of the brain.

Combating Alzheimer’s Disease Alzheimer’s type dementia is an age-related neurological disease, which currently affects 35 million people worldwide. As we shift to an aging population, the number of people suffering from neurological degenerative diseases is expected to quadruple by 2050 due to the ever-increasing gap between health and life expectancy. In the Western world, elderly people can expect their health to deteriorate to a level where they need care 8-11 years prior to the end of their life. There will be an increasing strain on government institutions that provide social and health care for the elderly with, for instance, care costs for Alzheimer’s patients in the United States (US) alone forecast to reach $1 trillion by 2050.

This article is available in full in the Winter 2014 issue of Nutraceuticals Now